Table 2

Adherence measures for SPAA and CCB+statin primary prevention patients

SPAA

CCB+Statin

(N = 1,537)

(N = 17,910)

p-value


6 Months

Number (%) of patients with PDC ≥80%

868

56.5%

3,825

21.4%

<.001

Mean PDC (SD)

0.73

(0.26)

0.49

(0.31)

Median PDC

0.83

0.50

<.001

12 Months

Number (%) of patients with PDC ≥ 80%

712

46.3%

3,529

19.7%

<.001

Mean PDC (SD)

0.66

(0.30)

0.46

(0.31)

Median PDC

0.75

0.46

<.001

18 Months

Number (%) of patients with PDC ≥ 80%

650

42.3%

3,342

18.7%

<.001

Mean PDC (SD)

0.62

(0.31)

0.43

(0.32)

Median PDC

0.72

0.42

<.001


Chapman et al. BMC Cardiovascular Disorders 2010 10:29   doi:10.1186/1471-2261-10-29

Open Data